Existing health disparities amongst ethnic minorities with diabetes have worsened during the COVID-19 pandemic, a new study published in the journal Diabetes Care has reported.
Academics from the University of Leicester are urging care services to address the disproportionate impact the pandemic has had on people from ethnic minority backgrounds after highlighting an increase in health inequalities.
In this review, the team of researchers from the UK and US examined the larger structural barriers in society that put ethnic minorities with diabetes at greater risk of severe COVID-19 outcomes.
These barriers include structural inequities in adequate housing, food, education, employment opportunities, and neighbourhood resources.
According to this extensive review, these barriers are important determinants of health for people with diabetes or COVID-19, particularly those in high-risk populations such as ethnic minorities.
The academics found that people from ethnic minority backgrounds can experience severe coronavirus outcomes because of their differences in comorbid conditions (the presence of one or more additional conditions often co-occurring with a primary condition), exposure risk and access to treatment.
Previous academic studies have failed to address wider structural issues that can trigger health inequalities amongst people from ethnic minority backgrounds.
The research was supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration (ARC) East Midlands and NIHR Leicester Biomedical Research Centre.
Professor Kamlesh Khunti CBE, Director of NIHR ARC East Midlands and the Real World Evidence Unit and Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, lead author of the review, said: “Diabetes is a risk factor for severe COVID-19, and the combination of these ethnic disparities may have contributed to the inequality of coronavirus outcomes for those living with the condition.
“As we now plan for recovery, improved surveillance, and risk factor management, it will be imperative that primary and specialist care services urgently focus on the disproportionate impact the pandemic has had on ethnic minority populations.”
“Only by taking a long-term, holistic view of health care will we, and particularly our most vulnerable populations, be able to cope better with future pandemics.”
NIHR ARC East Midlands funds vital work to tackle the region’s health and care priorities by speeding up the adoption of research onto the frontline of health and social care. The organisation puts in place evidence-based innovations which seek to drive up standards of care and save time and money.
NIHR ARC East Midlands is hosted by Nottinghamshire Healthcare NHS Foundation Trust and works in collaboration with the East Midlands Academic Health Science Network. It has bases at the University of Leicester and the University of Nottingham.
‘The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes’ is published in Diabetes Care.
Journal
Diabetes Care
Method of Research
Literature review
Subject of Research
People
Article Title
The Impact of the COVID-19 Pandemic on Ethnic Minority Groups With Diabetes
Article Publication Date
9-Aug-2022
COI Statement
K.K. has acted as a consultant or speaker or received grants for investigator-initiated studies for AstraZeneca, Novartis, Novo Nordisk, Sanofi, Lilly, Merck Sharp & Dohme, Boehringer Ingelheim, Bayer, Berlin-Chemie AG/Menarini Group, Janssen, and Napp Pharmaceuticals. K.K. is director of the University of Leicester Centre for Black Minority Ethnic Health, trustee of the South Asian Health Foundation, chair of the Ethnicity Subgroup of the U.K. Scientific Advisory Group for Emergencies (SAGE), and member of SAGE. M.P. has acted as a consultant or speaker for Bayer Pharmaceuticals, CME Outfitters, and PRIME in the past 3 years. M.P. is currently or has been a consultant or advisory board member for the Agency for Healthcare Research and Quality, American Diabetes Association, the American College of Physicians, the Centers for Disease Control and Prevention, the Centers for Medicare and Medicaid Services, the Illinois Department of Health, the Society of General Internal Medicine, and Physicians for Human Rights in the past 3 years. No other potential conflicts of interest relevant to this article were reported.